I am a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where my research focuses on molecular carcinogenesis and its interaction with food-based, cancer risk reduction strategies.

In particular, my work follows a bench-to-bedside, crop-to-clinic and food-to-pharma philosophy. I seek to define translationally relevant molecular profiles in oral carcinogenic progression that advance food-based intervention strategies.

One of my recent studies confirmed that antiapoptotic and proinflammatory biomarkers may represent emerging biomarkers for molecular efficacy in black raspberry-mediated oral cancer chemoprevention.

I have co-authored many articles in well-respected publications, including International Journal of Cancer, Molecular Carcinogenesis and Cancer Immunology, Immunotherapy.